Shinya Ugawa Selected Research

Shinya Ugawa Research Topics

Disease

5	Pain (Aches) 01/2023 - 10/2002
3	Hyperalgesia 01/2023 - 01/2015
2	Neoplasms (Cancer) 01/2023 - 08/2008
2	Fibrosis (Cirrhosis) 01/2022 - 02/2021
2	Inflammation (Inflammations) 01/2022 - 02/2015
2	Ischemia 01/2013 - 11/2003
2	Acidosis 01/2013 - 05/2005
2	Ganglion Cysts (Ganglion) 01/2011 - 03/2010
2	Melanoma (Melanoma, Malignant) 08/2008 - 02/2008
1	Hypersensitivity (Allergy) 01/2023
1	Myalgia 01/2023
1	Chronic Pain 01/2023
1	Congenital Hypothyroidism (Cretinism) 01/2022
1	Hypothyroidism 01/2022
1	Respiratory Tract Diseases (Respiratory Tract Disease) 02/2021
1	Airway Remodeling 02/2021
1	Asthma (Bronchial Asthma) 02/2021
1	Aneuploidy (Aneuploid) 01/2020
1	Hearing Loss (Hearing Impairment) 01/2020
1	Hypertension (High Blood Pressure) 11/2017
1	Neuralgia (Stump Neuralgia) 01/2015
1	Cryptorchidism (Undescended Testes) 04/2014
1	Retinal Degeneration 01/2013
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2013
1	Retinal Vein Occlusion 01/2013
1	Schizophrenia (Dementia Praecox) 12/2011
1	Carcinoma (Carcinomatosis) 08/2010
1	Urinary Bladder Neoplasms (Bladder Cancer) 08/2010
1	Reperfusion Injury 11/2003

Drug/Important Bio-Agent (IBA)

4	capsazepineIBA 01/2023 - 10/2002
3	CarrageenanIBA 01/2023 - 01/2015
3	Capsaicin (Zostrix)FDA Link 02/2015 - 10/2002
3	CationsIBA 02/2015 - 10/2002
3	Amiloride (Midamor)FDA LinkGeneric 01/2013 - 10/2002
3	Proteins (Proteins, Gene)FDA Link 08/2010 - 02/2008
3	Protons (Proton)IBA 05/2005 - 10/2002
3	AcidsIBA 08/2004 - 10/2002
2	Transient Receptor Potential ChannelsIBA 02/2015 - 01/2011
2	Analgesics (Analgesic Drugs)IBA 02/2015 - 09/2003
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 04/2014 - 08/2010
2	Retinaldehyde (Retinal)IBA 01/2013 - 11/2003
2	Acid Sensing Ion ChannelsIBA 01/2013 - 09/2003
2	Messenger RNA (mRNA)IBA 08/2010 - 02/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023
1	CytokinesIBA 01/2023
1	Interleukin-8 (Interleukin 8)IBA 01/2022
1	Interleukin-2 (IL2)IBA 01/2022
1	IodidesIBA 01/2022
1	IodineIBA 01/2022
1	Poly I-CIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	2,3,4-tri-O-acetylarabinopyranosyl isothiocyanate (AITC)IBA 02/2021
1	AnkyrinsIBA 02/2021
1	Phosphotransferases (Kinase)IBA 01/2020
1	OligosaccharidesIBA 01/2020
1	PrebioticsIBA 01/2020
1	AntigensIBA 01/2020
1	SaltsIBA 11/2017
1	MibefradilIBA 01/2015
1	NNC 55-0396IBA 01/2015
1	T-Type Calcium Channels (T-Type Calcium Channel)IBA 01/2015
1	Protein Isoforms (Isoforms)IBA 01/2015
1	Transcription Factors (Transcription Factor)IBA 04/2014
1	MicroRNAs (MicroRNA)IBA 04/2014
1	Neuroprotective AgentsIBA 01/2013
1	Aripiprazole (Abilify)FDA Link 12/2011
1	CalciumIBA 08/2010
1	Fluorescent Dyes (Fluorescent Probes)IBA 03/2010
1	diamidino compound 253-50IBA 03/2010
1	Menthol FDA Link 08/2008
1	Ion Channels (Ion Channel)IBA 02/2008
1	Epithelial Sodium ChannelsIBA 02/2008
1	AntibodiesIBA 11/2003
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 11/2003
1	Cell Adhesion MoleculesIBA 11/2003
1	SelectinsIBA 11/2003
1	adhesion receptorIBA 11/2003
1	P-SelectinIBA 11/2003

Therapy/Procedure

2	Ligation 01/2013 - 11/2003
1	Intramuscular Injections 01/2023
1	Intravitreal Injections 01/2013
1	Therapeutics 09/2003